Portfolio company
PATH FERTILITY
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops epigenetic sperm quality tests for men and clinicians to identify subfertility missed by standard semen analysis.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
FertereX
This company develops a photobiomodulation therapy device designed to improve sperm quality and testosterone levels for men experiencing fertility issues.
Posterity Health
This digital health platform provides male fertility testing, hormone management and urological consultations for men, employers and healthcare providers.
Paterna Biosciences
Paterna Biosciences develops in vitro spermatogenesis technology to produce functional sperm from stem cells for clinics treating male infertility.
Fellow Health
The company develops mail-in semen analysis and fertility testing kits for men, urology practices and reproductive health clinics.
Future Fertility
This company develops artificial intelligence software for oocyte quality assessment to assist fertility clinics and patients with reproductive treatment decisions.
Legacy
This company provides sperm testing and cryopreservation services for men through mail-in kits and digital health platforms.
Genomic Prediction
The company develops genetic screening tests for IVF embryos to assess disease risks for fertility clinics and prospective parents.
Genie
This company develops non-invasive diagnostics using menstrual blood to study uterine molecular biomarkers for patients experiencing infertility.
